| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23.1B | $21.6B | $21.5B | $21.1B | $19.2B | $16.9B | $17.8B | $17.1B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $7.0B | $6.0B | $5.6B | $6.1B | $5.7B | $7.6B | $5.4B | $5.3B |
| EPS (Basic) | $16.60 | $13.76 | $12.80 | $13.86 | $12.71 | $16.99 | $11.43 | $10.79 |
| EPS (Diluted) | $16.59 | $13.74 | $12.79 | $13.85 | $12.70 | $16.96 | $11.39 | $10.71 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $573.6B | $560.0B | $561.6B | $557.3B | $557.2B | $466.7B | $410.3B | $382.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | $45.3B | $5.9B | $6.4B | $7.4B | $6.6B | — | — |
| Total Liabilities | $512.9B | $505.6B | $510.4B | $511.5B | $501.5B | $412.6B | $361.0B | $334.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $60.6B | $54.4B | $51.1B | $45.8B | $55.7B | $54.0B | $49.3B | $47.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.4B | $7.9B | $10.1B | $9.1B | $7.2B | $4.7B | $7.4B | $7.8B |
| Investing Cash Flow | $-15.6B | $-3.2B | $-6.4B | $-13.4B | $-2.8B | $-51.1B | $-25.0B | $-4.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $4.7B | $-9.1B | $-3.9B | $3.4B | $-3.4B | $48.4B | $17.1B | $-3.5B |